N-Cyano-N'-methyl-N''-[2-[(5-methyl-1H-imidazol-4-yl)methylsulphinyl]ethyl]guanidine
CAS: 54237-72-8
Ref. 3D-IC58267
1g | 538,00 € | ||
50mg | 136,00 € | ||
100mg | 192,00 € | ||
250mg | 297,00 € | ||
500mg | 410,00 € |
Informação sobre produto
- 2-Cyano-1-methyl-3-[2-[[(5-methylimidazol-4-yl)methyl]sulphinyl]ethyl]guanidineCimetidine impurity E
- Guanidine, N-cyano-N′-methyl-N′′-[2-[[(4-methyl-1H-imidazol-5-yl)methyl]sulfinyl]ethyl]-
- (±)-Cimetidine S-oxide
- N-Cyano-N′-methyl-N′′-[2-[[(4-methyl-1H-imidazol-5-yl)methyl]sulfinyl]ethyl]guanidine
- Guanidine, N-cyano-N′-methyl-N′′-[2-[[(5-methyl-1H-imidazol-4-yl)methyl]sulfinyl]ethyl]-
- Cimetidine sulfoxide
N-Cyano-N'-methyl-N''-[2-[(5-methyl-1H-imidazol-4-yl)methylsulphinyl]ethyl]guanidine is an acetylcholinesterase inhibitor that is used to treat Alzheimer's disease. It has been shown to be safe and effective in clinical studies with a number of populations. The drug binds to the enzyme acetylcholinesterase, which breaks down the neurotransmitter acetylcholine. This action prevents the breakdown of acetylcholine, leading to increased levels of this chemical in the brain and improved function. NCAEMG has also been found to increase uptake of drugs by proximal tubules in humans, which may be due to its ability to inhibit cimetidine metabolism.
Propriedades químicas
Consulta técnica sobre: 3D-IC58267 N-Cyano-N'-methyl-N''-[2-[(5-methyl-1H-imidazol-4-yl)methylsulphinyl]ethyl]guanidine
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.